These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 6933738

  • 1. [Serum prolactin levels during therapy of prostatic cancer with oestradiol-17 beta-undecylate and cyproterone acetate (author's transl)].
    Spona J, Lunglmayr G.
    Wien Klin Wochenschr; 1980 Jul 04; 92(14):494-7. PubMed ID: 6933738
    [Abstract] [Full Text] [Related]

  • 2. Effect of oestrogen or cyproterone acetate treatment on adrenocortical function in prostate carcinoma patients.
    Schürmeyer T, Graff J, Senge T, Nieschlag E.
    Acta Endocrinol (Copenh); 1986 Mar 04; 111(3):360-7. PubMed ID: 2421511
    [Abstract] [Full Text] [Related]

  • 3. [Therapy of prostatic cancer with cyproterone acetate].
    Maier U.
    Wien Klin Wochenschr; 1988 Jan 08; 100(1):16-9. PubMed ID: 2964127
    [Abstract] [Full Text] [Related]

  • 4. Effect of cyproterone/acetate (SH-714) on plasma prolactin in patients with prostatic cancer.
    Holub G, Lunglmayr G, Spona J.
    Urol Res; 1981 Jan 08; 9(5):245-7. PubMed ID: 6458145
    [Abstract] [Full Text] [Related]

  • 5. [Serum concentrations of prolactin, growth hormone, and alpha-fetoprotein under long-term administration of an oral contraceptive containing cyproterone acetate (author's transl)].
    Bellmann O, Bröschen-Zywietz C, Fichte K.
    Geburtshilfe Frauenheilkd; 1978 Jul 08; 38(7):549-54. PubMed ID: 78873
    [Abstract] [Full Text] [Related]

  • 6. Treatment of advanced prostatic cancer with parenteral cyproterone acetate: a phase III randomised trial.
    Jacobi GH, Altwein JE, Kurth KH, Basting R, Hohenfellner R.
    Br J Urol; 1980 Jun 08; 52(3):208-15. PubMed ID: 7000222
    [Abstract] [Full Text] [Related]

  • 7. [Therapy of virginal prostatic cancer with cyproterone acetate].
    Maier U.
    Z Urol Nephrol; 1985 Apr 08; 78(4):181-7. PubMed ID: 3160180
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cyproterone acetate, testosterone, LH, FSH, and prolactin levels in plasma after intramuscular application of cyproterone acetate in patients with prostatic cancer.
    Rost A, Schmidt-Gollwitzer M, Hantelmann W, Brosig W.
    Prostate; 1981 Apr 08; 2(3):315-22. PubMed ID: 6458025
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Endocrine effects of cyproterone acetate in patients with prostatic cancer.
    Isurugi K, Fukutani K, Ishida H, Hosoi Y.
    J Urol; 1980 Feb 08; 123(2):180-3. PubMed ID: 7354512
    [Abstract] [Full Text] [Related]

  • 15. A randomized phase II trial of flutamide vs chlormadinone acetate in previously untreated advanced prostatic cancer. The Japan Flutamide Study Group.
    Akaza H, Usami M, Kotake T, Koiso K, Aso Y.
    Jpn J Clin Oncol; 1993 Jun 08; 23(3):178-85. PubMed ID: 7688829
    [Abstract] [Full Text] [Related]

  • 16. Equivalent and sufficient effects of leuprolide acetate and goserelin acetate to suppress serum testosterone levels in patients with prostate cancer.
    Fujii Y, Yonese J, Kawakami S, Yamamoto S, Okubo Y, Fukui I.
    BJU Int; 2008 May 08; 101(9):1096-100. PubMed ID: 18190637
    [Abstract] [Full Text] [Related]

  • 17. [Effects of cyproterone acetate on cardiovascular risk factors in patients with carcinoma of the prostate (author's transl)].
    Varenhorst E, Karlberg BE, Risberg B, Wallentin L, Wranne B.
    Urologe A; 1981 Jul 08; 20(4):218-22. PubMed ID: 6455834
    [Abstract] [Full Text] [Related]

  • 18. [Hormone therapy of prostatic cancer (author's transl)].
    Altwein JE, Jacobi GH.
    Urologe A; 1980 Nov 08; 19(6):350-7. PubMed ID: 7193368
    [Abstract] [Full Text] [Related]

  • 19. Treatment of prostatic cancer with cyproterone acetate as monotherapy.
    Beurton D, Grall J, Davody P, Cukier J.
    Prog Clin Biol Res; 1987 Nov 08; 243A():369-77. PubMed ID: 2958861
    [No Abstract] [Full Text] [Related]

  • 20. Low-dose cyproterone acetate plus mini-dose diethylstilbestrol--a protocol for reversible medical castration.
    Goldenberg SL, Bruchovsky N, Gleave ME, Sullivan LD.
    Urology; 1996 Jun 08; 47(6):882-4. PubMed ID: 8677581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.